BETOPTIC Side Effects

6967205-7 | Ocular Pemphigoid
on Aug 26, 2010 Female patient from GREECE , 76 years of age, was diagnosed with glaucoma (What is glaucoma?) and was treated with Betoptic (View Usage). Patient experienced the following unwanted or unexpected effects: ocular pemphigoid. Betoptic dosage: Ophthalmic.

6720417-X | Ocular Pemphigoid
Patient was taking Betoptic (View Usage). Patient had the following side effects: ocular pemphigoid on Apr 26, 2010 from GREECE Additional patient health information: Female patient , 76 years of age, . Betoptic dosage: Ophthalmic.

6300303-X | Bradycardia, Myocardial Infarction, Tremor
Adverse event was reported on Jul 21, 2009 by a Female patient taking Betoptic (View Usage) (Dosage: Bid, Ophthalmic) was diagnosed with glaucoma (What is glaucoma?) and. Location: BULGARIA , 72 years of age, After Betoptic was administered, patient had the following side effects: bradycardia, myocardial infarction, tremor. During the same period patient was treated with LORISTA (LOSARTAN POTASSIUM) (View Lorista (losartan Potassium) Review and Lorista (losartan Potassium) Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), VITREOLENT (IODUCYL) (View Vitreolent (ioducyl) Review and Vitreolent (ioducyl) Label ).

6162236-1 | Dry Eye, Headache, Retinal Detachment
on Apr 17, 2009 Male patient from UNITED STATES , 70 years of age, weighting 175.0 lb, was diagnosed with intraocular pressure increased and was treated with Betoptic (View Usage). Patient experienced the following unwanted or unexpected effects: dry eye, headache (What is headache?), retinal detachment. Betoptic dosage: .


5862372-0 | Abortion, Amniotic Cavity Disorder, Blood Human Chorionic Gonadotropin Decreased
on Aug 20, 2008 Female patient from GERMANY , 43 years of age, was diagnosed with open angle glaucoma and was treated with Betoptic (View Usage). Patient had the following side effects: abortion (What is abortion?), amniotic cavity disorder, blood human chorionic gonadotropin decreased. Betoptic dosage: Ophthalmic. During the same period patient was treated with UTROGEST (PROGESTERONE) (View Utrogest (progesterone) Review and Utrogest (progesterone) Label ), PREDALON (CHORIONIC GONADOTROPHIN (View Predalon (chorionic Gonadotrophin Review and Predalon (chorionic Gonadotrophin Label ).

5852762-4 | Amniotic Cavity Disorder, Blood Human Chorionic Gonadotropin Decreased
Patient was taking Betoptic (View Usage). After Betoptic was administered, patient had the following side effects: amniotic cavity disorder, blood human chorionic gonadotropin decreased on Aug 04, 2008 from GERMANY Additional patient health information: Female patient , 44 years of age, was diagnosed with open angle glaucoma and. Betoptic dosage: Tid Ophthalmic. During the same period patient was treated with UTROGEST (PROGESTERONE) (View Utrogest (progesterone) Review and Utrogest (progesterone) Label ).

5736469-X | Asthenia, Atrioventricular Block, Blood Pressure Systolic Increased, Cardiac Failure, Dyspnoea, Oedema Peripheral
Adverse event was reported on Apr 28, 2008 by a Male patient taking Betoptic (View Usage) (Dosage: Ophthalmic) . Location: FRANCE , 83 years of age, Patient experienced the following unwanted or unexpected effects: asthenia, atrioventricular block, blood pressure systolic increased, cardiac failure, dyspnoea, oedema peripheral. During the same period patient was treated with CORDARONE (View Cordarone Review and Cordarone Label ), COZAAR (View Cozaar Review and Cozaar Label ), SINTROM (View Sintrom Review and Sintrom Label ), BEFIZAL (BEZAFIBRATE) (View Befizal (bezafibrate) Review and Befizal (bezafibrate) Label ), TAMSULOSIN HCL (View Tamsulosin Hcl Review and Tamsulosin Hcl Label ), AVODART (View Avodart Review and Avodart Label ). Patient was hospitalized.

5500072-7 | Arrhythmia, Atrial Fibrillation, Malaise, Presyncope, Wheezing
on Oct 10, 2007 Female patient from UNITED KINGDOM , 85 years of age, was diagnosed with glaucoma (What is glaucoma?) and was treated with Betoptic (View Usage). Patient had the following side effects: arrhythmia (What is arrhythmia?), atrial fibrillation (What is atrial fibrillation?), malaise, presyncope, wheezing. Betoptic dosage: . During the same period patient was treated with TIMOLOL MALEATE (1 Df 2/1 Days) (View Timolol Maleate Review and Timolol Maleate Label ), ADCAL (CARBAZOCHROME) (View Adcal (carbazochrome) Review and Adcal (carbazochrome) Label ), CANDESARTAN (CANDESARTAN) (View Candesartan (candesartan) Review and Candesartan (candesartan) Label ), CIPROFIBRATE (CIPROFIBRATE) (View Ciprofibrate (ciprofibrate) Review and Ciprofibrate (ciprofibrate) Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), RISEDRONATE SODIUM (View Risedronate Sodium Review and Risedronate Sodium Label ).

5343480-X | Asthenia, Bradycardia, Computerised Tomogram Abnormal, Diarrhoea, Flushing, Hypotension, Lung Infection, Malaise, Sinusitis
on May 25, 2007 Male patient from CANADA , 77 years of age, was diagnosed with carcinoid tumour and was treated with Betoptic (View Usage). After Betoptic was administered, patient had the following side effects: asthenia, bradycardia, computerised tomogram abnormal, diarrhoea, flushing, hypotension, lung infection, malaise, sinusitis (What is sinusitis?). Betoptic dosage: . During the same period patient was treated with LIPITOR (View Lipitor Review and Lipitor Label ), XALATAN (View Xalatan Review and Xalatan Label ), SANDOSTATIN LAR (10 Mg Every 4 Four Weeks) (View Sandostatin Lar Review and Sandostatin Lar Label ), METHAZOLAMIDE (View Methazolamide Review and Methazolamide Label ), BRIMONIDINE OPHTHALMIC (View Brimonidine Ophthalmic Review and Brimonidine Ophthalmic Label ), PARIET (View Pariet Review and Pariet Label ).

5141957-3 | Asthenia, Bradycardia, Diarrhoea, Hypotension, Lung Infection, Malaise, Sinusitis
Patient was taking Betoptic (View Usage). Patient experienced the following unwanted or unexpected effects: asthenia, bradycardia, diarrhoea, hypotension, lung infection, malaise, sinusitis (What is sinusitis?) on Sep 06, 2005 from CANADA Additional patient health information: Male patient , 77 years of age, was diagnosed with carcinoid tumour and. Betoptic dosage: . During the same period patient was treated with LIPITOR (View Lipitor Review and Lipitor Label ), XALATAN (View Xalatan Review and Xalatan Label ), SANDOSTATIN LAR (10 Mg Every 4 Four Weeks) (View Sandostatin Lar Review and Sandostatin Lar Label ), METHAZOLAMIDE (View Methazolamide Review and Methazolamide Label ), BRIMONIDINE OPHTHALMIC (View Brimonidine Ophthalmic Review and Brimonidine Ophthalmic Label ), PARIET (View Pariet Review and Pariet Label ).

5114609-3 | Asthenia, Bradycardia, Diarrhoea, Hypotension, Lung Infection, Sinusitis
Adverse event was reported on Sep 06, 2005 by a Male patient taking Betoptic (View Usage) (Dosage: ) was diagnosed with carcinoid tumour and. Location: CANADA , 77 years of age, Patient had the following side effects: asthenia, bradycardia, diarrhoea, hypotension, lung infection, sinusitis (What is sinusitis?). During the same period patient was treated with LIPITOR (View Lipitor Review and Lipitor Label ), XALATAN (View Xalatan Review and Xalatan Label ), SANDOSTATIN LAR (10 Mg Every 4 Four Weeks) (View Sandostatin Lar Review and Sandostatin Lar Label ), METHAZOLAMIDE (View Methazolamide Review and Methazolamide Label ), BRIMONIDINE OPHTHALMIC (View Brimonidine Ophthalmic Review and Brimonidine Ophthalmic Label ), PARIET (View Pariet Review and Pariet Label ).

4684940-4 | Intraocular Pressure Increased, Mydriasis, Surgery
on May 13, 2005 Male patient from , 69 years of age, was diagnosed with open angle glaucoma and was treated with Betoptic (View Usage). After Betoptic was administered, patient had the following side effects: intraocular pressure increased, mydriasis, surgery (What is surgery?). Betoptic dosage: Opht. Patient was hospitalized.